In depth
IgG4-related disease and exercise
There's no exercise research in this disease at all, which is unusual even among rare conditions. What there is instead is a guideline about corticosteroids, and most people with this diagnosis take them for a stretch. So the reason to move comes through the treatment rather than through the diagnosis.
What the research found.
A review screened 167 papers on IgG4-related disease, and just one of them could serve as a care guideline. That one is a consensus statement written by experts drawn from several specialties. No score exists for how active the illness is or how much harm it has done to anybody.
The 2017 American College of Rheumatology guideline covers every adult on a long corticosteroid course. It strongly advises four things, and those are getting calcium and vitamin D right, doing weight-bearing and strength-building exercise, stopping smoking, and cutting back on alcohol. That advice reaches a reader through their treatment rather than through their diagnosis.
One trial gave 194 people either a drug called obexelimab or a dummy shot, weekly for a year. Flares hit 26 of the 97 on the drug, at 26.8 percent, against 53 of 97 on the dummy shot, at 54.6 percent. That group also needed far less rescue corticosteroid over the year, at a P value of 0.004.
Della-Torre and colleagues, New England Journal of Medicine, 2026
There is no exercise research here
No exercise study of any kind exists in IgG4-related disease. Nothing published here has tested exercise or activity, and getting people moving again after a flare hasn't been looked at. That's a thinner base than any other illness covered on this site.
The review of the field screened 167 papers and found one that could serve as a care guideline. It also listed what is missing, which includes shared rules for sorting cases, formal rules for the diagnosis, treatment advice backed by good trials, and any score for how active the illness is. That last absence is the one that counts for this page in particular.
Without an agreed way to measure the illness, whether anything changes it can't be tested at all. That's part of why no exercise study exists here. The missing research comes on top of missing measurement, and the second of those came first.
What that absence does and doesn't mean
It's worth separating two things that get confused with each other constantly here. No trial has shown that exercise helps this illness, and no trial has shown that it does nothing for it either. An absence of research isn't a finding, in either one of those two directions.
So be wary of anybody offering you an exercise program written for IgG4-related disease in particular. A set frequency, length, and intensity for this illness would have been invented rather than sourced, because there's no trial anybody could draw one from. There are no trials at all in this disease.
What that leaves is the ordinary case for staying active, which holds for you as it holds for anyone. It also leaves one thing more specific than that, and it comes through your treatment rather than through your diagnosis. The rest of this page is about that one more specific thing.
What applies through the corticosteroids
Most people with this diagnosis take corticosteroids for a stretch, and that brings the one firm recommendation this page can give you. The 2017 American College of Rheumatology guideline covers every adult starting or staying on a long course, at every age. It gives strong advice on four separate points, and they hang together.
Get your calcium and vitamin D right, do weight-bearing and strength-building exercise, stop smoking, and cut back on alcohol. Note where the exercise appears in that list, because it belongs alongside the nutrients and not instead of them. People read the first half of that list and skip the second.
Take those two words away with you, which are weight-bearing and strength. They tell you a kind of work rather than leaving you to guess at one, which is more than the rest of this subject manages. That advice holds whatever put you on the course in the first place.
Bone, and why it keeps coming up
A long corticosteroid course thins bone, and that's the clearest risk anybody has written down for people with this diagnosis. It's the reason the guideline calls for weight-bearing work in the first place. Everything else on this page is thinner than that one fact.
So asking about a bone density scan is a specific and fair request if you've been on a course a while. It's also the measurement that speaks most directly to the argument this page is making. Ask what the result would change as well, because that's the useful half of the answer.
Getting your calcium and vitamin D right is the other half of what the guideline advises. Ask to have your levels measured, because how you eat is a poor guide to what your blood level turns out to be. This illness can affect organs that change how you handle nutrients, and which organ is involved decides how much that counts.
What to watch for
Mention weight coming off when you didn't mean it to, and mention any change in your stools. Mention getting thirstier or going to the toilet more often, because corticosteroids raise blood sugar and that changes what exercise does to it. Those three are worth raising at an appointment when they happen.
Tell whoever supervises your exercise which organ is affected in your case. This illness settles in many different places, so two people with one diagnosis between them can need quite different things. That question counts for more here than it would in an illness with a single face.
Past all that, build from what you can do now. There's no protocol to follow here and no score to judge your progress by. So track what you can do instead, which is a fair stand-in for a disease score in an illness that hasn't got one.
Common misconceptions.
Myth. There must be exercise guidance for this disease.
Reality. There's no exercise study of any kind in IgG4-related disease, which is where this has to start. The field's own review screened 167 papers and found just one that could serve as a care guideline, and it listed what is missing, including any score for how active the illness is. So anything specific you're told about exercising with this diagnosis has come from somewhere else.
Myth. No research means exercise must be risky here.
Reality. That isn't what it means at all, because it means it has never been measured. The general case for staying active holds here as it does for anybody else, and if you're on a long corticosteroid course, a guideline asks you for weight-bearing and strength work in those words. The absence is in the research about this illness rather than in the reasons to move.
Myth. There's a way to tell whether exercise is helping my disease.
Reality. Not in this illness, and not yet anywhere. The review of the field listed what is missing, and one item on that list is any score for how active the disease is, so there's no agreed way to measure it. Without one, whether anything changes it can't be tested, which is part of why no exercise study exists.
Myth. A program written for another rheumatic disease will do.
Reality. It's what gets used, because there's nothing else available to use. It also hasn't been tested here, and this illness settles in many organs, so two people with one diagnosis between them can be in quite different positions. Tell whoever supervises your exercise which organ is affected, because that changes what's sensible for you.
Cautions specific to this condition.
- The 2017 corticosteroid guideline asks for weight-bearing and strength work in anyone on a long course. Those are its own words. Your team can say whether it fits you.
- Ask about a bone density scan if you've been on corticosteroids a while. A long course brings a bone risk of its own.
- Tell whoever supervises your exercise which organ is affected. This disease looks completely different depending on where it settles.
- Ask for your vitamin levels. Measuring first is the safer order here.
- Mention weight coming off when you didn't mean it to. It has more than one possible cause in this illness.
- Mention getting thirstier, or going to the toilet more. Corticosteroids raise blood sugar, and that changes what exercise does to it.
Discuss any change with the rheumatologist who manages your care. Nothing here replaces that conversation.
Questions patients ask.
Is there exercise research in IgG4-related disease?
Not a single one, because nothing published here has tested exercise or activity. So any advice you're given for this diagnosis is borrowed from somewhere else, and usually the borrowing goes unmentioned. The plain case for staying active still holds for you, just as it holds for anybody else.
So why does this page exist?
To tell you the research isn't there, and to give you the part that is. Most people with this diagnosis take corticosteroids for a stretch, and a guideline covers that, asking for weight-bearing and strength work in those words. That's a real reason with a real document behind it, and it isn't a claim about your illness.
What does the glucocorticoid guideline say?
It covers every adult starting or staying on a long corticosteroid course, at every age. It strongly advises four things, which are getting calcium and vitamin D right, doing weight-bearing and strength-building exercise, stopping smoking, and cutting back on alcohol. That reaches you through your treatment rather than your diagnosis, and it holds whatever put you on the course.
Why is bone the thing that keeps coming up?
Because a long corticosteroid course thins bone, and most people with this diagnosis are on one for a while. That's the clearest written-down risk that applies to you, and weight-bearing and strength work is part of the published answer to it. So asking about a bone density scan is a fair request if you've been on a course for a while, and it's a specific one.
Is my steroid dose fixed?
No, and that counts a good deal for your bones. One trial of 194 people measured how much rescue corticosteroid each group needed over a year, and the group on the drug needed far less, at a P value of 0.004. So how much you end up taking depends on what else is holding the disease down, which is worth raising with your team.
How do I know if exercise is helping my disease?
You can't, and neither can anybody else, because no agreed measure of this disease exists. The review of this field listed what is missing, and one item is any score for how active the disease is, so there's no number to follow. What you can measure is what you can do, and that's worth tracking for yourself.
Is there a program I should follow?
No program exists for this illness at all. Anybody handing you a frequency, a duration, and an intensity for IgG4-related disease invented all three of them. So start from what you can do now, with somebody who knows there's no protocol to follow here, which is unsatisfying and accurate both at once.
What should I be careful about?
That depends on which organ is affected, and it counts for more here than in most illnesses. Mention weight coming off when you didn't mean it to, and mention any change in your stools. Mention getting thirstier or going to the toilet more, because corticosteroids raise blood sugar, and tell whoever supervises your exercise where the disease has settled.
References.
- Buckley L; Guyatt G; Fink H et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis. Arthritis & Rheumatology. 2017;69:1521-1537. 10.1002/art.40137GRADE-based clinical practice guideline
- Iaccarino L; Talarico R; Scirè C et al. IgG4-related diseases: state of the art on clinical practice guidelines. RMD Open. 2019;4:e000787. 10.1136/rmdopen-2018-000787Systematic literature review for clinical practice guidelines in IgG4-related disease
- Della-Torre E; Baker MC; Zhang W et al. Obexelimab for the Treatment of IgG4-Related Disease. N Engl J Med. 2026. 10.1056/NEJMoa2601337Phase 3
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.